Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan-Bupropion vs SSRIs in Major Depressive Disorder
NCT06957223Completed
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dextromethorphan and bupropion in major depressive disorder (MDD) (2 arms). Primary endpoint: Change in Depression Severity at 6 weeks. Started May 2025; status: completed.
02
Drugs
dextromethorphanbupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06957223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06957223.